慢性阻塞性肺疾病发生危险因素及健康管理应用进展

doi:10.3969/j.issn.1006-3110.2024.05.030

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (731 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是临床上常见疾病,发病率呈逐年上升趋势,严重者可导致死亡,影响患者生存质量,现已成为全球范围内广受关注的公共卫生问题之一。明确COPD危险因素,加强健康管理,对科学防治COPD具有重要意义。本研究针对COPD的危险因素及健康管理现状进行综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	覃倩
	胥巧云
	代术蓉

关键词 ：慢性阻塞性肺疾病, 危险因素, 慢性病健康管理

Abstract：Chronic obstructive pulmonary disease (COPD) is a commondisease in clinical practice, and its incidence rate increases year by year. Severe COPD can lead to death and affect the patients’ quality of life, and it has become one of the public health problems that have attracted widespread attention worldwide. It is of great significance for scientific prevention and treatment of COPD to identify risk factors for COPD and strengthen health management. This study reviews risk factors for COPD and current status of health management.

Key words： chronic obstructive pulmonary disease risk factor chronic disease health management

收稿日期: 2023-05-23

PACS:

R563

作者简介: 覃倩(1991-),女,四川射洪人,本科,初级,主要从事慢性病健康管理工作。

引用本文:

覃倩, 胥巧云, 代术蓉. 慢性阻塞性肺疾病发生危险因素及健康管理应用进展[J]. 实用预防医学, 2024, 31(5): 637-641. QIN Qian, XU Qiaoyun, DAI Shurong. Progress in risk factors for chronic obstructive pulmonary disease and application of health management. , 2024, 31(5): 637-641.

链接本文:

https://www.syyfyx.com/CN/10.3969/j.issn.1006-3110.2024.05.030 或 https://www.syyfyx.com/CN/Y2024/V31/I5/637

[1] 马小玉,李鹏飞,台娜,等. 异丙托溴铵联合低分子肝素钙治疗老年慢性阻塞性肺疾病伴肺源性心脏病病人的疗效研究[J].实用老年医学,2022,36(7):680-683.
[2] 杨琳,姚丽,张志刚,等. 有创-无创序贯机械通气对慢性阻塞性肺疾病合并呼吸衰竭患者治疗效果的meta分析[J].中国呼吸与危重监护杂志,2020,19(4):351-358.
[3] 李然,刘晓芳,王玉红,等. 慢性阻塞性肺疾病稳定期患者共患疾病与死亡风险的关系研究[J]. 临床内科杂志, 2022, 39(4):241-245.
[4] Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022,399(10342):2227-2242.
[5] Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis[J]. Lancet Respir Med, 2022, 10(5):447-458.
[6] Buttery SC,Zysman M,Vikjord SAA,et al. Contemporary perspectives in COPD: patient burden, the role of gender and trajectories of multimorbidity[J]. Respirology, 2021, 26(5):419-441.
[7] Gausman V, Dornblaser D, Anand S, et al. Risk factors associated with early-onset colorectal cancer[J]. Clin Gastroenterol Hepatol, 2020, 18(12):2752-2759.
[8] 郑丹蕾,王红梅,刘耘充,等. 慢性阻塞性肺疾病患者血嗜酸粒细胞分布及临床特征[J].中华结核和呼吸杂志,2021,44(3):218-224.
[9] Ng R,Sutradhar R,Yao Z,et al. Smoking, drinking, diet and physical activity—modifiable lifestyle risk factors and their associations with age to first chronic disease[J]. Int J Epidemiol, 2020, 49(1):113-130.
[10] 田亚琼,李慧,邱婷,等. PTEN基因缺失激活核因子-κB介导肺泡上皮细胞衰老参与肺纤维化发病[J].中华结核和呼吸杂志,2020,43(1):26.
[11] Alder JK,Armanios M. Telomere-mediated lung disease[J]. Physiol Rev, 2022, 102(4):1703-1720.
[12] Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy[J]. Nat Rev Drug Discov, 2021, 20(9):689-709.
[13] Barnes PJ, Baker J, Donnelly LE. Autophagy in asthma and chronic obstructive pulmonary disease[J]. Clin Sci (Lond), 2022, 136(10):733-746.
[14] 高丛丛, 张吉玉, 陈先献,等. 山东省40岁及以上居民慢性阻塞性肺疾病患病情况及危险因素分析[J]. 现代预防医学, 2022,49(18):3271-3282.
[15] Ruvuna L, Sood A. Epidemiology of chronic obstructive pulmonary disease[J]. Clin Chest Med, 2020, 41(3):315-327.
[16] 袁菲,陈慧,朱丹,等. IL-17A基因多态性与慢性阻塞性肺疾病易感性和严重程度的关系[J].江苏医药,2021,47(12):1219-1222.
[17] 张力,刘璇,陆沈栋,等. α1-抗胰蛋白酶在稳定期慢性阻塞性肺疾病合并支气管扩张患者血清中的表达及其临床意义[J].医学临床研究,2020,37(2):193-195,198.
[18] Silva CP,Kamens HM. Cigarette smoke-induced alterations in blood: a review of research on DNA methylation and gene expression[J]. Exp Clin Psychopharmacol, 2021, 29(1):116-135.
[19] 程炜炜,鲁晓怡,周晓莉,等. 外周血LTA4H基因多态性rs7971150位点检测在老年慢性阻塞性肺疾病患者中的临床意义[J].老年医学与保健,2021,27(2):266-269.
[20] Witusik A, Mokros L, Szemraj J, et al. The-463G/A and-129G/A myeloperoxidase-encoding gene polymorphism in chronic obstructive pulmonary disease[J]. Adv Respir Med, 2020, 88(2):116-122.
[21] 白毅,施晓坤,蒋德雄,等. 平昌县农村地区慢阻肺流行病学特征及相关因素分析[J].实用预防医学,2023,30(10):1239-1242.
[22] 吴士昱,王林峰. 气道微生态与慢性阻塞性肺疾病[J].生命的化学,2022,42(4):684-690.
[23] 于旭华,丁美祝,谢丹,等. 香烟烟雾联合脂多糖对气道炎症及衰老的影响[J].暨南大学学报:自然科学与医学版,2021,42(2):172-180.
[24] Malik P,Hoidal JR,Mukherjee TK. Implication of RAGE polymorphic variants in COPD complication and anti-COPD therapeutic potential of sRAGE[J]. COPD, 2021, 18(6):737-748.
[25] Radicioni G,Ceppe A,Ford AA,et al. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort[J]. Lancet Respir Med, 2021, 9(11):1241-1254.
[26] Yang IA,Jenkins CR,Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment[J]. Lancet Respir Med, 2022, 10(5):497-511.
[27] Lu Z,Van Eeckhoutte HP,Liu G,et al. Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 204(6):667-681.
[28] 刘颖楠,王旭明,申静蓉,等. 云南省纳西族居民烟草暴露相关慢性阻塞性肺疾病的经济负担研究[J].中国全科医学,2021,24(32):4099-4103.
[29] 查震球,何玉琢,徐伟,等. 吸烟对慢性阻塞性肺疾病及呼吸道症状的影响[J].中华疾病控制杂志,2020,24(1):46-51,56.
[30] Garcia E,Rice MB. It’s not just a smoking-related disease: outdoor pollution may increase risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 203(9):1057-1058.
[31] 张丽江,卢耀勤,柴淑萍,等. 空气颗粒物暴露下职业人群肺功能现状与影响因素分析[J].职业与健康,2021,37(24):3345-3348.
[32] 周玮,姜淑娟. 大气细颗粒物污染与慢性阻塞性肺疾病气道炎症和氧化应激关系研究[J].中国医药导报,2020,17(5):125-128.
[33] 蒋先雁,陈剑宇,师春立,等. 2019—2020年自贡市大气污染物暴露对慢性阻塞性肺疾病住院人次的影响[J].预防医学情报杂志,2022,38(6):825-831.
[34] Aghaeimeybodi F, Samadzadeh G, Safari ZH, et al. Comparison of chronic obstructive pulmonary diseases induced by wood smoke and tobacco smoke[J]. Tanaffos, 2021, 20(3):268-276.
[35] Shetty BSP, D’Souza G, Padukudru Anand M. Effect of indoor air pollution on chronic obstructive pulmonary disease (COPD) deaths in Southern Asia—a systematic review and meta-analysis[J]. Toxics, 2021, 9(4):85.
[36] Pathak U,Gupta NC,Suri JC. Risk of COPD due to indoor air pollution from biomass cooking fuel: a systematic review and meta-analysis[J]. Int J Environ Health Res, 2020, 30(1):75-88.
[37] 李刚,袁翠堂,罗勇,等. 上海市崇明岛不同程度生物燃料的使用与慢性阻塞性肺疾病及肺功能的相关性分析[J].临床肺科杂志,2022,27(1):24-28.
[38] Murgia N,Gambelunghe A. Occupational COPD-the most under-recognized occupational lung disease?[J]. Respirology, 2022, 27(6):399-410.
[39] 朱钧,杨汀,王辰. 慢性阻塞性肺疾病与职业暴露关系的系统性评价与荟萃分析[J].国际呼吸杂志,2022,42(2):118-125.
[40] 赵倩,范亚丽,马瑞敏,等. 矽肺合并慢性阻塞性肺疾病患病率和危险因素分析[J].中华劳动卫生职业病杂志,2022,40(8):602-606.
[41] Hogea SP, Tudorache E, Fildan AP, et al. Risk factors of chronic obstructive pulmonary disease exacerbations[J]. Clin Respir J, 2020, 14(3):183-197.
[42] Smith BM, Kirby M, Hoffman EA, et al. Association of dysanapsis with chronic obstructive pulmonary disease among older adults[J]. JAMA, 2020, 323(22):2268-2280.
[43] Zheng B,Soares de Moura C,Machado M,et al. Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis[J]. Clin Exp Rheumatol, 2022, 40(7):1280-1284.
[44] 陈华萍,胡明冬,张君国,等. 慢性阻塞性肺疾病合并症及其对预后的影响[J].解放军医学杂志,2020,45(8):834-839.
[45] 阮春燕,林俏丽,蔡倩,等. 饮酒与慢性阻塞性肺疾病风险关系的meta分析[J].实用预防医学,2022,29(11):1328-1332.
[46] Fitzsimmons DA,Thompson J,Bentley CL,et al. Comparison of patient perceptions of Telehealth-supported and specialist nursing interventions for early stage COPD: a qualitative study[J]. BMC Health Serv Res, 2016, 16(1):420.
[47] 刘杨, 王凯, 肖革新,等. “全科医学+”紧密型医共体下慢性病管理模式构建研究:基于国际慢性病管理模式和经验[J]. 中国全科医学, 2022, 25(16):1923-1928.
[48] Donner CF,ZuWallack R,Nici L. The role of telemedicine in extending and enhancing medical management of the patient with chronic obstructive pulmonary disease[J]. Medicina (Kaunas), 2021, 57(7):726.
[49] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 慢性阻塞性肺疾病基层诊疗指南(实践版·2018)[J].中华全科医师杂志,2018,17(11):871-877.
[50] 唐星瑶,黄可,李薇,等. 河南省驻马店市基层医疗机构医生慢性阻塞性肺疾病知识掌握情况及影响因素调查研究[J].中华全科医师杂志,2022,21(5):422-429.
[51] 贾存波,黄可,张春瑜,等. 我国18个地市慢性阻塞性肺疾病诊疗能力现状调查[J].中国临床医生杂志,2021,49(6):669-671.
[52] 彭博,张小娟,姜骁桐,等. 基层医疗卫生机构慢性阻塞性肺疾病基本药物与诊断设备可获得性调查研究[J].中国全科医学,2022,25(7):771-781.
[53] 杨旭,李爱阳,迟春花. 《基层医疗卫生机构改善医疗服务措施》实施后北京市密云区社区卫生服务中心慢性阻塞性肺疾病管理情况调查[J].中华全科医师杂志,2021,20(7):748-753.
[54] 钟南山,曾广翘. 慢性呼吸疾病的防治策略[J].中国临床保健杂志,2020,23(1):1-5.
[55] 中国县域慢性阻塞性肺疾病筛查专家共识编写专家组, 中国医师协会呼吸医师分会基层工作委员会, 杨汀,等. 中国县域慢性阻塞性肺疾病筛查专家共识(2020年)[J]. 中华医学杂志, 2021, 101(14):989-994.
[56] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3):170-205.
[57] 许东晴,穆怀典,周健红,等. 社区联合病房延伸干预措施对合并焦虑和(或)抑郁慢性阻塞性肺疾病患者的疗效分析[J].上海医学,2021,44(4):257-261.
[58] 李凡,盛春风,王欢英. 提高全科医生在慢性病早期诊断和管理中的地位和作用—以慢性阻塞性肺疾病为例[J].中国全科医学,2021,24(9):1044-1050.
[59] 钟晓夏. 基于“互联网+”的健康管理模式对慢性阻塞性肺疾病稳定期患者肺功能、急性加重次数及生活质量的影响[J].医学临床研究,2020,37(11):1684-1687.